- Organizations: Biogen
Research
Real-world pegcetacoplan data shows VA benefits through 18 months
EHR and AI-based imaging analysis presented at ASRS demonstrates SYFOVRE advantages extending to GA patients with concomitant wet AMD.Research
New SYFOVRE data extend GA benefit to patients with concurrent wet AMD
SYFOVRE demonstrates reduced photoreceptor and RPE loss in GA patients and those with concomitant nAMD.
Business
Biogen is purchasing Apellis
With an estimated price tag of $5.6 billion, the acquisition includes the FDA-approved SYFOVRE.
Products